In ₹ Crore except Per Share Latest Annual	KIMS FY26	APOLLOHOSP FY26	MAXHEALTH FY26	FORTIS FY26	Peer Average
Valuation — at last close
P/E	116.85×	60.26×	57.42×	◆ 55.04×	57.57× +103%
P/B	12.54×	12.34×	7.71×	◆ 5.79×	8.62× +46%
EV/EBITDA	39.46×	32.11×	38.18×	◆ 28.74×	33.01× +20%
Market Cap	₹28,184 Cr	₹1.17L Cr	₹82,862 Cr	₹57,339 Cr	₹85,737 Cr -67%
Growth
Revenue CAGR 3Y	21.12%	14.94%	◆ 22.43%	13.17%	16.85% +25%
Revenue CAGR 5Y	24.04%	19.03%	◆ 27.30%	17.76%	21.36% +13%
Net Income CAGR 3Y	-12.87%	◆ 33.35%	9.34%	18.91%	20.53% -163%
Revenue YoY (latest Q)	◆ 35.33%	20.56%	16.70%	17.46%	18.24% +94%
Net Income YoY (latest Q)	-56.00%	◆ 38.41%	4.87%	2.26%	15.18% -469%
Profitability
EBITDA Margin	20.54%	14.94%	◆ 26.79%	22.84%	21.52% -5%
Net Income Margin	6.20%	7.94%	◆ 17.23%	11.66%	12.28% -49%
Return on Common Equity	11.01%	◆ 21.95%	14.33%	11.08%	15.79% -30%
Return on Capital Employed	9.09%	◆ 18.20%	12.63%	12.62%	14.48% -37%
Return on Assets	3.59%	◆ 9.35%	8.89%	7.18%	8.47% -58%
Credit & Quality
Total Debt/Equity	1.27×	0.57×	0.32×	◆ 0.28×	0.39× +226%
Interest Coverage	2.56×	6.44×	◆ 7.64×	5.20×	6.43× -60%
Scale — latest FY
Revenue / Total Income	₹3,905 Cr	₹25,229 Cr	₹8,373 Cr	₹9,128 Cr	₹14,243 Cr -73%
Net Income	₹242 Cr	₹2,003 Cr	₹1,442 Cr	₹1,064 Cr	₹1,503 Cr -84%
Total Assets	₹7,759 Cr	₹22,197 Cr	₹17,231 Cr	₹15,966 Cr	₹18,465 Cr -58%
EPS	₹6.03	₹135.04	₹14.83	₹13.8	₹54.56 -89%
Book Value per Share	₹56.19	₹659.26	₹110.43	₹131.07	₹300.25 -81%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.